Treatment for patients with cervical spondylosis Musculoskeletal Diseases
Conditions
Interventions
Control group: Participants receive standard pharmacological management for cervical spondylosis, namely NSAIDs (meloxicam 7.5 mg, celecoxib 200 mg, or diclofenac 50 mg), taken twice daily for 14 days
Sponsors
Ho Chi Minh City Hospital for Rehabilitation – Occupational Diseases
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Adults aged 18 – 60 years diagnosed with cervical spondylosis, with at least one of the following: 1.1. Cervical spine syndrome with neck pain, paraspinal tightness, or restricted cervical mobility; 1.2. Cervical radicular symptoms, including arm pain, paresthesia, or symptom provocation with neck movements; or 1.3. Vertebral artery-related symptoms, such as occipital headache, dizziness, tinnitus, or visual disturbance associated with neck posture. 2. Radiographic confirmation with cervical X-ray showing Kellgren-Lawrence grade 1 – 2 degenerative changes was required. 3. Magnetic resonance imaging (MRI) was obtained when needed to clarify root involvement or exclude alternative pathology. 4. Participants also needed to have no contraindications to oral NSAIDs.
Exclusion criteria
Exclusion criteria: 1. Clinical signs of cervical myelopathy 2. Cervical disc herniation on MRI 3. Secondary causes of neck pain (trauma, tumour, infection, osteoporosis, inflammatory disorders, or soft-tissue pathology) 4. Pregnancy or breastfeeding 5. Indication for surgical management 6. Severe hepatic impairment 7. Severe renal failure without dialysis 8. Recent or active gastrointestinal or intracranial bleeding, or systemic bleeding disorders 9. Uncontrolled severe heart failure
Countries
Viet Nam
Contacts
Public ContactMinh Nguyen Huu Duc
Outcome results
None listed